entity

ITGAX

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about ITGAX: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

7Connections
2Hypotheses
1Analyses
3Outgoing
4Incoming
0Experiments
1Debates

No AI portrait yet

Outgoing (3)

TargetRelationTypeStr
benchmark_ot_ad_answer_key:ITGAXdata_indataset_row0.00
h-a5bc82c685targeted_byhypothesis1.00
synaptic engulfmentmediatesphenotype0.70

Incoming (4)

SourceRelationTypeStr
benchmark_ot_ad_answer_key:ITGAXdata_indataset_row0.00
h-a5bc82c685targetshypothesis1.00
37727065highly expressed inpaper0.90
TRETINOIN (ATRA)targetsdrug0.80

Targeting Hypotheses (2)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Downstream Pathway Selective Modulation: ITGAX (αXβ2) Integr 0.501 synaptic-biology Does SPP1-mediated synaptic engulfment r
ITGAX/CD11c Targeting to Eliminate Pro-inflammatory DAM in A 0.408 neurodegeneration Microglial subtypes in neurodegeneration

Mentioning Analyses (1)

Scientific analyses that reference this entity

Does SPP1-mediated synaptic engulfment represent beneficial clearance or patholo

synaptic biology | 2026-04-07 | 8 hypotheses Top: 0.813

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found

Debates (1)

Multi-agent debates referencing this entity

While SPP1 absence prevents synaptic loss, it's unclear whether this represents

closed · Rounds: 4 · Score: 0.69 · 2026-04-21

Related Research

Hypotheses and analyses mentioning ITGAX in their description or question text

No additional research found